|
ANKRD49 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.90798504668055E-14 |
| Normal-vs-Stage2 |
4.68669991704473E-10 |
| Normal-vs-Stage3 |
3.33066907387547E-16 |
| Normal-vs-Stage4 |
1.81188397618826E-12 |
| Stage1-vs-Stage2 |
2.421800E-01 |
| Stage1-vs-Stage3 |
1.735270E-03 |
| Stage1-vs-Stage4 |
1.175550E-03 |
| Stage2-vs-Stage3 |
2.893800E-01 |
| Stage2-vs-Stage4 |
1.096820E-01 |
| Stage3-vs-Stage4 |
4.324000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.52889999841477E-08 |
| Normal-vs-Asian |
2.02950000000035E-05 |
| Caucasian-vs-AfricanAmerican |
4.937800E-01 |
| Caucasian-vs-Asian |
6.517100E-03 |
| AfricanAmerican-vs-Asian |
3.507700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01474384450739E-13 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.290200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.19821988073954E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63791202822949E-12 |
| Normal-vs-Age(81-100Yrs) |
4.23699999996252E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.694200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.111870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.570200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.771800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.962030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.020600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.81600000000293E-05 |
| Classical-VS-Follicular |
1.710410E-01 |
| Classical-VS-Other |
2.744800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.61938999999611E-05 |
| Tall-VS-Other |
6.097600E-02 |
| Tall-VS-Normal |
2.44249065417534E-15 |
| Follicular-VS-Other |
2.223800E-01 |
| Follicular-VS-Normal |
5.11160003213718E-09 |
| Other-VS-Normal |
1.678440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.44169137633799E-15 |
| Normal-vs-N1 |
2.17900000043514E-07 |
| N0-vs-N1 |
8.621000E-01 |
|
|
